Home › Hemophilia › New York
Hemophilia clinical trials in New York
4 studies for Hemophilia are looking for participants at sites in New York.
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- Cornell University||Joan & Sanford I. Weill Medical College, New York
- Weill Cornell Medical College-New York Presbyterian Hospital, New York
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 2, 2026 · NCT05568719ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Western New York BloodCare, Buffalo
- Northwell Health Hemostasis and Thrombosis Center at Long Island Jewish and Cohen Children's Medical Center, Hyde Park
- Weill Cornell Medical College - New York Presbyterian Hospital, New York
- and 2 more
RecruitingObservational study
All ages · All sexes · Updated Aug 17, 2026 · NCT04398628Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
- Northwell Health HTC, New Hyde Park
RecruitingPhase 3
Ages 1 to 74 · Men · Updated Jul 1, 2026 · NCT05145127SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
- Northwell Health, Long Island Jewish, New Hyde Park
RecruitingPhase 4
Ages 12 to 100 · All sexes · Updated Jan 12, 2026 · NCT04647227From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.